Multi-stakeholder Alliance

The multi-stakeholder Alliance is governed by principles and values that underpin the joint working interactions, as well as the objectives and modus operandi for TRANSFORM.



European Medicines Agency

In individual capacity:

  • Marc Dooms, Senior Orphan Drug Pharmacist, University Hospitals Leuven
  • Stuart Faulkner, Programme and Operations Manager at the Center for the Advancement of Sustainable Medical Innovation (CASMI), Oxford University

@TRANSFORM_CGT on Twitter Follow us →

TRANSFORM MEP @TomislavSokol is giving a video address at the GAPP JA Final Dissemination Conference, highlighting TRANSFORM’s plans to discuss the revision of the BTC legislation in the first semester of 2022. #MEPsforATMPs ➡️ see the video:
21 January at 11:35am
Today’s Oslo Medicines Initiative webinar will focus on one of TRANSFORM’s priority issues:“Models for financing novel medicines to support innovation as a global public good”. This is crucial for safe and timely patient access to ATMPs. TRANSFORM looks forward to the discussion.
20 January at 10:20am
Check out this webinar series hosted by the Oslo Medicines Initiative, with interventions from a range of stakeholders on how to improve access to novel medicines in the WHO European region. @WHO_Europe
13 January at 12:40pm